Dr Kolberg Provides A Global Perspective On Biosimilar Integration | Latest News RSS feed

Dr Kolberg Provides A Global Perspective On Biosimilar Integration - Latest News


Roche Holding's (RHHBY) CEO Dr. Severin Schwan on Q1 2017 Results - Earnings Call Transcript

Roche Holding Ltd. (ADR) (OTCQX:RHHBY) Q1 2017 Results Earnings Conference Call April 27, 2017 8:00 AM ET Executives Dr. Severin Schwan - CEO Daniel ... with some of our major brands facing up coming ... read more

Dr. Reddy's Laboratories Announces the Launch of Sevelamer Carbonate Tablets in the U.S. Market

“This launch represents Dr. Reddy’s expertise and commitment to provide ... Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom ph... read more

Global API industry entering a new growth phase

Advancements in the production technology have enabled production of biosimilars ... such as Teva, Dr Reddy's and Boehringer Ingelheim continue to invest heavily in the API industry and remain the lea... read more

Looking for another news?


Digital Health Leader Nik Leist to Present CPhI North America Keynote Address

Leist will outline the steps required, including customizing machinery and partnering with global pharmaceutical companies ... conversations across the healthcare field and enables a true integration ... read more


Mylan NV (MYL) Q4 2017 Results - Earnings Call Transcript

Having built a one-of-a-kind platform whose strength, diversification and resilience positions us like no other company to provide ... global community we now live. As a result, we're able to leverage ... read more

Global Picture Archiving and Communication Systems (PACS) Industry

ProLogistix, ResourceMFG, Select and... at 16:30 Global Contract Research Organization Market 2018-2025 - Market Opportunities with Growing Biosimilars and Biologics Market The "Contract Research Orga... read more

Dr Reddy Laboratories : Announces the Launch of Sevelamer Carbonate Tablets in the U.S. Market

“This launch represents Dr. Reddy’s expertise and commitment to provide ... Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom ph... read more

Johnson & Johnson Q3 2017 Earnings Conference Call Transcript (JNJ)

Good morning, and welcome to Johnson & Johnson's third quarter 2017 earnings conference call. All participants will be in listen ... I am Joe Wolk, Vice President of Investor Relations. I would like t... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us